Skip to main content
Clinical Trials/NCT01839266
NCT01839266
Completed
Not Applicable

Prognostic Factors for Acute Pulmonary Embolism in Critically Ill Patients

Yonsei University1 site in 1 country200 target enrollmentNovember 2011

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Acute Pulmonary Embolism (PE)
Sponsor
Yonsei University
Enrollment
200
Locations
1
Primary Endpoint
prognostic factors of overall survival
Status
Completed
Last Updated
13 years ago

Overview

Brief Summary

Acute pulmonary embolism (PE) is an important cause of in-hospital mortality and may be rapidly fatal if not diagnosed and treated. Despite recent advances in diagnostic and therapeutic modalities, it is still one of the important causes of hospital mortality. Previous several reports have described the variable outcome of patients with PE with reported mortality rate ranging from 8.1% (stable patients) to 25% (with cardiogenic shock) and 65% (post cardiopulmonary resuscitation). Nevertheless, there are no published studies from Korean hospitals that assessed the outcome of acute PE treated in the hospital with IV unfractionated heparin. We conducted this study to determine the outcome, risk factors, clinical characteristics and demographics of patients with acute PE and to identify possible demographic and clinical factors associated with prognosis.

Registry
clinicaltrials.gov
Start Date
November 2011
End Date
April 2013
Last Updated
13 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • patients admitted to the Severance Hospital, Yonsei University Health System with primary diagnosis of PE between January 2008 and December
  • (diagnosed by CT and treated in the hospital with IV unfractionated heparin)

Exclusion Criteria

  • diagnosis was prior to arrivalor
  • anticoagulation was contraindicated
  • diagnosis was not confirmed by CT

Outcomes

Primary Outcomes

prognostic factors of overall survival

Time Frame: change of acute pulmonary embolism(PE) for duration of hospital stay an expected average of 12 months

In-hospital all-cause mortality with acute pulmonary embolism(PE) treated in the hospital with IV unfractionated heparin

Study Sites (1)

Loading locations...

Similar Trials